Mediastinum,
Год журнала:
2024,
Номер
8, С. 51 - 51
Опубликована: Дек. 1, 2024
Diagnosis
of
pathology
in
the
mediastinum
has
proven
quite
challenging,
given
wide
variability
both
benign
and
malignant
diseases
that
affect
a
diverse
array
structures.
This
complexity
led
to
development
many
different
non-invasive
invasive
diagnostic
modalities.
Historically,
diagnosis
relied
on
imaging
modalities
such
as
chest
X-ray,
computed
tomography
(CT),
magnetic
resonance
imaging,
positron
emission
topography.
Once
suspicious
lesion
was
identified
with
one
these
techniques,
gold
standard
for
mediastinoscopy
staging
disease.
More
recently,
minimally
techniques
CT-guided
biopsy,
endobronchial
ultrasound
transbronchial
needle
aspiration,
endoscopic
fine
aspiration
have
revolutionized
mediastinum.
review
provides
comprehensive
analysis
all
available
diagnosing
mediastinal
disease
an
emphasis
bronchoscopic
techniques.
Literature
search
performed
via
PubMed
database.
We
included
types
articles
study
designs,
including
original
research,
meta-analyses,
reviews,
abstracts.
Minimally
ultrasound-transbronchial
(EBUS-TBNA)
ultrasound-fine
(EUS-FNA)
demonstrated
high
yield
low
complication
rate
made
significant
difference
time
lives
patients.
There
continues
be
innovation
field
bronchoscopy
new
technologies
confocal
laser
endomicroscopy,
optical
coherence
tomography,
artificial
intelligence.
Bronchoscopy
is
will
continue
integral
modality
Diagnostics,
Год журнала:
2024,
Номер
14(9), С. 965 - 965
Опубликована: Май 6, 2024
Benign
and
malignant
mediastinal
lesions
are
not
infrequently
encountered
in
clinical
practice.
Mediastinoscopy
has
long
been
considered
the
gold
standard
evaluating
pathology.
Since
its
introduction
into
practice,
endobronchial-ultrasonography-guided
transbronchial
fine
needle
aspiration
(EBUS-TBNA)
replaced
mediastinoscopy
as
initial
procedure
of
choice
to
evaluate
stage
lung
cancer.
Its
diagnostic
yield
benign
less
common
malignancies,
however,
remained
limited.
This
led
different
proceduralists
investigate
additional
procedures
improve
EBUS-TBNA.
In
recent
years,
published
reports
concluded
that
addition
EBUS-guided
intranodal
forceps
biopsy
(IFB)
cryobiopsy
(TBCB)
EBUS-TBNA
increases
especially
uncommon
malignancies.
The
purpose
this
review
is
describe
how
EBUS-IFB
EBUS-TBCB
performed,
compare
their
yields,
discuss
limitations
potential
complications.
addition,
will
conclude
with
a
proposed
algorithm
on
incorporate
Frontiers in Medicine,
Год журнала:
2025,
Номер
12
Опубликована: Янв. 30, 2025
Introduction
Mediastinal
and
hilar
lymphadenopathies
are
primarily
diagnosed
pathologically.
Contact
laser-assisted
endobronchial
ultrasound-guided
tunnel
drilling
biopsy
(EBUS-TDB),
which
uses
a
laser
as
tunneling
incision
tool,
may
yield
more
satisfactory
specimens
than
conventional
transbronchial
needle
aspiration
(EBUS-TBNA),
thereby
improving
the
diagnostic
yield.
This
study
aims
to
evaluate
value
safety
of
contact
EBUS-TDB
compared
EBUS-TBNA
in
assessment
mediastinal
lymph
nodes.
Methods
retrospective
included
patients
who
presented
our
hospital
between
October
2022
April
2024
with
or
nodes
short
diameter
≥
1
cm
on
computed
tomography
(CT)
abnormally
increased
node
metabolism
positron
emission
(PET)-CT.
All
underwent
both
procedures
successively.
Results
Overall,
278
were
study,
244
cases
confirmed.
The
rates
(
p
-values)
for
pulmonary
extrapulmonary
malignancies,
lymphoma,
sarcoidosis,
tuberculosis
96.6%
vs.
76.3%
(0.043),
100%
67.7%
(−),
88.9%
31.1%
(0.555),
69.2%
30.8%
(0.049),
respectively.
No
serious
adverse
events
occurred
during
after
either
procedure.
Conclusion
EBUS-TBNB
demonstrates
superior
performance
evaluation
nodes,
making
it
an
alternative
enhanced
precision.
Journal of Thoracic Disease,
Год журнала:
2024,
Номер
16(7), С. 4217 - 4228
Опубликована: Июль 1, 2024
Background:
Endobronchial
ultrasound
(EBUS)-guided
mediastinal/hilar
cryobiopsy
(MedCryoBx)
is
a
relatively
new
modality,
being
combined
with
EBUS-transbronchial
needle
aspiration
(TBNA)
to
improve
yield
in
the
diagnosis
of
intrathoracic
adenopathy.
This
meta-analysis
aims
investigate
diagnostic
MedCryoBx
versus
EBUS-TBNA
for
Methods:
We
conducted
systematic
search
using
Google
Scholar,
Embase,
and
PubMed/MEDLINE
studies
about
adenopathy
EBUS-TBNA.
Two
authors
separately
reviewed
inherent
bias
Quality
Assessment
Data
Abstraction
Synthesis-2
(QUADAS-2)
tool.
Inverse
Variance
weighting
random
effects
methodology
was
used
meta-analysis.
Pooled
yields
overall
subgroups
were
estimated.
Complications
reviewed.
Results:
Ten
844
patients
undergoing
either
biopsy
procedure
final
analysis.
A
total
554
underwent
704
Meta-analysis
showed
pooled
91%
(504
554)
81%
(567
704)
EBUS-TBNA,
odds
ratio
(OR)
2.5
[95%
confidence
interval
(CI):
1.6
3.91;
P<0.001],
I2
20%.
Subgroup
analysis
benign
conditions
increased
OR
7.95
(91%
58%
P<0.001)
an
25%.
lymphoma
statistically
significant
increase
11.48
(87%
29%
P=0.001).
Mild
bleeding
(36.5%)
without
any
intervention
most
common
complication.
Bleeding
requiring
(0.7%)
noted
patients.
Pneumothorax
(0.4%)
pneumomediastinum
less
this
Conclusions:
very
promising
tool
It
has
improved
over
possibly
lymphoproliferative
diseases,
but
so
lung
cancer.
The
complication
rates
are
comparable
Scientific Reports,
Год журнала:
2024,
Номер
14(1)
Опубликована: Авг. 12, 2024
Abstract
EBUS-guided
transbronchial
mediastinal
cryobiopsy
(TBMC)
has
emerged
as
a
promising
biopsy
tool
for
diagnosing
hilar
and
pathologies.
However,
several
fundamental
technical
aspects
of
TBMC
remain
unexplored.
This
study
aims
to
determine
the
optimal
number
cryo-passes
freezing
time
ultrathin
cryoprobe
in
EBUS-TBMC
concerning
specimen
size
procedural
diagnostic
yield.
We
conducted
retrospective
chart
review
patients
with
lesions
who
underwent
between
January
2021
April
2023
across
three
hospitals
Malaysia.
A
total
129
procedures
were
successfully
completed,
achieving
an
overall
yield
88.4%.
Conclusive
associated
larger
sizes
(7.0
vs.
5.0
mm,
p
<
0.01).
Specimen
demonstrated
positive
correlation
(
0.01),
plateauing
at
4.1–6.0
mm.
significant
was
also
observed
both
0.01)
0.05).
Diagnostic
plateaued
after
2–3
cryo-passes.
In
contrast,
longer
times
trended
towards
smaller
specimens
lower
yield,
though
not
reaching
statistical
significance.
The
highest
recorded
3.1–4.0
s
time.
safety
profile
remains
favourable,
one
case
(0.8%)
pneumothorax
nine
cases
(7%)
self-limiting
bleeding.
our
cohort,
performance
achieve
aggregate
mm
appeared
optimal.
Further
prospective
studies
are
needed
validate
these
findings.
Monaldi Archives for Chest Disease,
Год журнала:
2024,
Номер
unknown
Опубликована: Июль 24, 2024
Endobronchial
ultrasound
(EBUS)-guided
mediastinal
cryobiopsy
is
a
new
modality
for
sampling
lymph
nodes.
The
data
regarding
the
diagnostic
yield
and
utility
of
still
limited.
Consecutive
patients
who
were
undergoing
EBUS-guided
transbronchial
needle
aspiration
(EBUS-TBNA)
recruited
in
this
study.
We
subjected
enrolled
to
after
obtaining
their
informed
consent.
final
diagnosis
was
made
with
clinical-pathological-radiological
assessment
clinical-radiological
follow-up.
A
total
101
Adequacy
achieved
EBUS-TBNA
92.07%,
compared
98.01%
cryobiopsy.
Diagnostic
yields
67.32%
86.13%,
respectively
(p=0.001).
EBUS
patterns
failed
predict
crobiopsy.
No
significant
complications
observed.
To
conclude,
improves
EBUS-TBNA.
Monaldi Archives for Chest Disease,
Год журнала:
2024,
Номер
unknown
Опубликована: Фев. 19, 2024
Dear
Editor,The
recent
study
by
Madan
et
al.
provides
valuable
information
on
the
utility
of
intranodal
cryobiopsy
or
forceps
to
endobronchial
ultrasound
-
transbronchial
needle
aspiration
(EBUS-
TBNA)
during
sampling
mediastinal
lymph
nodes.
It
found
that
cryoprobe
acquires
a
larger
tissue
and
increases
diagnostic
yield.
However,
increase
in
yield
was
statistically
not
significant...
Research Square (Research Square),
Год журнала:
2024,
Номер
unknown
Опубликована: Окт. 25, 2024
AbstractBackground:
Mediastinal
and
hilar
lymphadenopathies
are
primarily
diagnosed
pathologically.
Compared
to
traditional
endobronchial
ultrasound-guided
transbronchial
needle
aspiration
(EBUS-TBNA),
contact
laser-assisted
tunnel
drilling
biopsy
(EBUS-TDB)
using
a
laser
as
tunnelling
incision
tool
may
yield
more
satisfactory
specimens,
thereby
improving
the
diagnostic
yield.
Therefore,
this
study
aims
evaluate
value
safety
of
EBUS-TDB
compared
EBUS-TBNA
for
mediastinal
lymph
nodes.
Methods:
This
retrospective
included
patients
who
presented
our
hospital
between
October
2022
April
2024
with
or
nodes
short
diameter
≥
1
cm
on
CT
abnormally
increased
node
metabolism
PET-CT
successively
completed
procedures.
Results:
Overall,
278
were
in
study,
244
cases
confirmed.
The
rates
(p-values)
pulmonary
extrapulmonary
malignancies,
lymphoma,
sarcoidosis,
tuberculosis
96.6%
vs.
76.3%
(0.043),
100%
67.7%
(−),
88.9%
31.1%
(0.555),
69.2%
30.8%
(0.049),
respectively.
No
serious
adverse
events
occurred
during
after
surgery.
Conclusion:
Contact
EBUS-TBNB
is
superior
diagnosis
be
used
an
alternative
EBUS-TBNA.